首页|益生元在2型糖尿病肾病Ⅳ期患者中的应用效果

益生元在2型糖尿病肾病Ⅳ期患者中的应用效果

扫码查看
目的 探讨益生元在2型糖尿病肾病Ⅳ期患者中的应用效果。方法 选择2020年6月至2022年6月九江市第一人民医院肾内科收治的80例2型糖尿病肾病Ⅳ期患者为研究对象,按照随机数字表法将其分为观察组和对照组,每组40例。对照组给予常规治疗,观察组在对照组方法的基础上另给予混合型菊粉。比较两组患者治疗前后的血清白蛋白(ALB)、血红蛋白(Hb)、肾功能指标及炎症指标等实验室指标,比较两组患者的急性胃肠损伤(AGI)评分、并发症发生率、二次住院率等预后指标。结果 治疗前,两组患者的各实验室指标比较,差异无统计学意义(P>0。05)。观察组治疗后的血清白蛋白(HbA1c)、C反应蛋白(CRP)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、血肌酐(SCr)、血尿素氮(BUN)指标均低于治疗前,ALB、Hb、估算肾小球滤过率(eGFR)均高于治疗前,差异有统计学意义(P<0。05)。对照组治疗后的CRP低于治疗前,差异有统计学意义(P<0。05);对照组治疗前后的ALB、HbA1c、Hb、CRP、IL-6、TNF-α、SCr、BUN、eGFR指标比较,差异无统计学意义(P>0。05)。治疗后,观察组的ALB、eGFR均高于对照组,HbA1c、CRP、IL-6、TNF-α、SCr、BUN均低于对照组,差异有统计学意义(P<0。05)。观察组的AGI评分、并发症发生率、二次住院率均低于对照组,胃肠道恢复时间短于对照组,差异有统计学意义(P<0。05)。结论 益生元能有效改善2型糖尿病肾病患者的肠道菌群紊乱,减少毒素蓄积,延缓肾功能恶化。
Application effect of prebiotics in stage Ⅳ patients with type 2 diabetic nephropathy
Objective To investigate the application effect of prebiotics in stage Ⅳ patients with type 2 diabetic nephropathy.Methods A total of 80 patients with stage Ⅳ type 2 diabetic nephropathy admitted to the Department of Nephrology,Jiu Jiang NO.1 People's Hospital from June 2020 to June 2022 were selected as research subjects.According to random number table method,the patients were divided into observation group and control group,with 40 cases in each group.The laboratory indexes such as serum albumin(ALB),hemoglobin(Hb),renal function indexes and inflammatory indexes before and after treatment were compared between the two groups.The prognosis indexes such as acute gastrointestinal injury(AGI)score,incidence of complications,and secondary hospitalization rate were compared between the two groups.Results Before treat-ment,there were no statistically significant differences in laboratory indexes between the two groups(P>0.05).After treat-ment,glycosylated hemoglobin(HbA1c),C-reactive protein(CRP),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),serum creatinine(SCr)and blood urea nitrogen(BUN)in the observation group were lower than those before treatment,and ALB.Hb and estimated glomerular filtration rate(eGFR)were higher than those before treatment,and the differences were statistically significant(P<0.05).The CRP of the control group after treatment was lower than that before treatment,and the difference was statistically significant(P<0.05).There were no significant differences in ALB,HbA1c,Hb,CRP,IL-6,TNF-α,SCr,BUN and eGFR in the control group before and after treatment(P>0.05).After treatment,the ALB and eGFR of the observation group were higher than those of the control group,and the HbA1c,CRP,IL-6,TNF-α,SCr and BUN were lower than those of the control group,and the differences were statistically significant(P<0.05).The AGI score,complication rate and secondary hospitalization rate of the observation group were lower than those of the control group,and the gastrointestinal recovery time was shorter than that of the control group,and the dif-ferences were statistically significant(P<0.05).Conclusion Prebiotics can effectively improve intestinal flora disorder,re-duce toxin accumulation and delay renal function deterioration in patients with type 2 diabetic nephropathy.

Type 2 diabetic nephropathyPrebioticsIntestinal flora disorderIndicators of inflammationRenal function

许海波、陈薇、江罗佳

展开 >

江西省九江市第一人民医院肝病科,江西九江 332000

江西省九江市第一人民医院康复医院,江西九江 332000

江西省九江市第一人民医院肾内科,江西九江 332000

2型糖尿病肾病 益生元 肠道菌群紊乱 炎症指标 肾功能

江西省卫生健康委科技计划项目江西省中医药管理局科技计划项目江西省九江市重点研发计划-指导性计划项目

2023114242021A078S2022ZDYFN340

2024

中国当代医药
中国保健协会 当代创新(北京)医药科学研究院

中国当代医药

影响因子:1.215
ISSN:1674-4721
年,卷(期):2024.31(4)
  • 20